Schwotzer Nora, Provot François, Ville Simon, Daniel Laurent, Le Fur Awena, Kissling Sébastien, Jourde-Chiche Noémie, Karras Alexandre, Moreau Anne, Augusto Jean-François, Gnemmi Viviane, Perrochia Hélène, Bataille Stanislas, Le Quintrec Moglie, Goujon Jean-Michel, Rotman Samuel, Fakhouri Fadi
Transplantation Center, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland.
Department of Nephrology and Renal Transplantation, CHRU de Lille, Lille, France.
Kidney Int Rep. 2021 Jan 6;6(3):746-754. doi: 10.1016/j.ekir.2020.12.030. eCollection 2021 Mar.
Myelodysplastic syndromes (MDS) are characterized by a high prevalence of associated autoimmune manifestations. Kidney involvement has been rarely reported in MDS patients. We report on the spectrum of kidney pathological findings in MDS patients.
We retrospectively identified MDS patients who had undergone a kidney biopsy between 2001 and 2019 in nine Swiss and French nephrology centres.
Nineteen patients (median age 74 years [63-83]) were included. At the time of kidney biopsy, eleven (58%) patients had extra-renal auto-immune manifestations and sixteen (84%) presented with acute kidney injury. Median serum creatinine at diagnosis was 2.8 mg/dL [0.6-8.3] and median urinary protein to creatinine ratio was 1.2 g/g [0.2-11]. Acute tubulo-interstitial nephritis (TIN) was present in seven (37%) patients. Immunofluorescence study in one patient with acute TIN disclosed intense IgG deposits along the tubular basement membrane and Bowman's capsule. Other kidney pathological features included ANCA-negative pauci-immune necrotizing and crescentic glomerulonephritis (n = 3), membranous nephropathy (n = 2), IgA nephropathy (n = 1), IgA vasculitis (n = 1), immunoglobulin-associated membrano-proliferative glomerulonephritis type I (n=1), crescentic C3 glomerulopathy (n = 1), fibrillary glomerulonephritis (n = 1) and minimal change disease (n = 1). Eleven (58%) patients received immunosuppressive treatments, among whom one developed a severe infectious complication. After a median follow-up of 7 month [1-96], nine (47%) patients had chronic kidney disease stage 3 (n = 6) or 4 (n = 3) and five (26%) progressed to end-stage kidney disease. Three patients died.
MDS are associated to several autoimmune kidney manifestations, predominantly acute TIN. MDS are to be listed among the potential causes of autoimmune TIN.
骨髓增生异常综合征(MDS)的特征是相关自身免疫表现的高患病率。MDS患者中肾脏受累情况鲜有报道。我们报告了MDS患者的肾脏病理检查结果范围。
我们回顾性地确定了2001年至2019年间在9个瑞士和法国肾脏病中心接受肾脏活检的MDS患者。
纳入了19名患者(中位年龄74岁[63 - 83岁])。在进行肾脏活检时,11名(58%)患者有肾外自身免疫表现,16名(84%)患者出现急性肾损伤。诊断时血清肌酐中位数为2.8mg/dL[0.6 - 8.3],尿蛋白与肌酐比值中位数为1.2g/g[0.2 - 11]。7名(37%)患者存在急性肾小管间质性肾炎(TIN)。1名急性TIN患者的免疫荧光研究显示沿肾小管基底膜和鲍曼囊有强烈的IgG沉积。其他肾脏病理特征包括抗中性粒细胞胞浆抗体(ANCA)阴性的寡免疫坏死性和新月体性肾小球肾炎(n = 3)、膜性肾病(n = 2)、IgA肾病(n = 1)、IgA血管炎(n = 1)、免疫球蛋白相关的I型膜增生性肾小球肾炎(n = 1)、新月体性C3肾小球病(n = 1)、纤维性肾小球肾炎(n = 1)和微小病变病(n = 1)。11名(58%)患者接受了免疫抑制治疗,其中1名发生了严重的感染并发症。中位随访7个月[1 - 96]后,9名(47%)患者处于慢性肾脏病3期(n = 6)或4期(n = 3),5名(26%)进展至终末期肾病。3名患者死亡。
MDS与多种自身免疫性肾脏表现相关,主要是急性TIN。MDS应被列为自身免疫性TIN的潜在病因之一。